Search This Blog

Tuesday, November 12, 2019

NextCure EPS misses by $0.02, misses on revenue

NextCure (NASDAQ:NXTC): Q3 GAAP EPS of -$0.37 misses by $0.02.
Revenue of $1.58M misses by $1.86M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)